The Price of Inaction to the Global Islamic Terror Movement
25 November 2015
David Adesnik, Policy Director at the Foreign Policy Initiative, discusses the Paris attacks, the price of U.S. inaction, ISIS' resiliency and the Syrian refugee crisis.
0:00 0:00

Related Podcasts

Foreign Policy and U.S. Global Interests
29 May 2026
The Honorable Francis Rooney, former U.S. Congressman and Ambassador to the Holy See, discusses the Trump Administration’s foreign policy, the state of U.S.-Vatican relations, and Pope Leo’s Encyclical on Artificial Intelligence.
Price Controls, Single-Payer Systems and Other Disastrous Healthcare Ideas
04 April 2025
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.
The Negative Consequences of Drug Price Controls for Patients
02 September 2024
Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.
Government Price Controls for Prescription Drugs Are Bad Medicine for Americans
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
Biden Price Controls Undermine Cancer Moonshot
01 March 2024
Sally Pipes, President and CEO at the Pacific Research Institute, discusses how President Biden's drug price controls undermine his Cancer Moonshot initiative, and the ultimate impact price controls will have on patient lives, innovation, and research and development.
The Truth About Drug Price Controls
13 October 2022
Sally Pipes, President and CEO of Pacific Research Institute, discusses the likely disastrous effects of drug price control provisions contained in the Inflation Reduction Act and why Congress should embrace a free-market vision when it comes to healthcare by lowering taxes, encouraging innovation and expanding access.